ニコチン経口溶解性薄膜の2030年までの市場予測： タイプ、投与強度、流通チャネル、用途、エンドユーザー、地域別の世界分析

Stratistics MRCによると、ニコチン経口溶解性薄膜の世界市場は、2024年に1億1,000万米ドルを占め、予測期間中にCAGR 5.86％で成長し、2030年までに1億5,000万米ドルに達すると予想されています。

ニコチン経口溶解性薄膜は、ニコチンを効果的に供給しながら、口腔内の粘膜から速やかに吸収されるように設計された革新的な禁煙補助剤です。これらの薄く柔軟なフィルムは素早く溶けるため、禁煙欲求を管理し、タバコ依存を軽減しようとするユーザーに目立たず便利な選択肢を提供します。一般的に無糖で風味があり、ガムやパッチといった従来のニコチン代替療法に代わるものを好む消費者にアピールしています。禁煙への現代的なアプローチとして、これらのフィルムは禁煙への道のりをサポートすることを目的としています。

高まる禁煙意識

禁煙意識の高まりは、効果的な禁煙補助薬に対する消費者の需要を促進することで、市場に大きな影響を与えます。公衆衛生キャンペーンや教育イニシアティブが喫煙のリスクを強調するにつれて、従来のタバコ製品に代わるものを求める個人が増加しています。このような意識の高まりは、禁煙欲求を管理するための控えめで便利な方法を提供する、溶解可能なフィルムのような革新的なソリューションの採用を促進します。その結果、メーカーは製品の提供やマーケティング活動を拡大するよう促され、市場の成長を後押ししています。

限られた認知度

ニコチン経口溶解性薄膜フィルムの認知度は限定的であり、潜在的なユーザーはこの効果的な禁煙代替手段を知らない可能性があるため、市場成長の妨げとなります。このような馴染みのなさは、消費者がより伝統的なニコチン製品を代わりに選ぶなど、採用率の低下を招く可能性があります。その結果、メーカーは市場でのプレゼンスを拡大し、こうした革新的な製品の利点を広める上で課題に直面します。そのため、市場の成長の妨げとなっています。

利便性と裁量

利便性と慎重さは、市場に影響を与える重要な要因です。これらの製品は、ニコチンデリバリーのための携帯可能で使いやすい代替手段を提供するからです。小型であるため、人目を引くことなくどこにでも持ち運ぶことができ、欲求を管理するためのより個人的な方法を求める人々にとって魅力的です。このような利便性はユーザー体験を向上させ、普及を促し、これらの製品に対する需要を促進します。消費者が禁煙のために目立たない選択肢を優先しているため、メーカー各社は革新的な製品を開発・拡大する意欲に燃えており、市場の成長をさらに後押ししています。こうして市場の成長が促進されます。

消費者の嗜好

消費者の嗜好は、ガム、パッチ、電子タバコなど、他のニコチン代替製品をユーザーが好む場合、市場にマイナスの影響を与える可能性があります。消費者がこれらの代替品の方がより効果的、あるいは使いやすいと認識した場合、薄膜製品に対する需要は減少する可能性があります。さらに、溶解性フィルムの有効性や安全性に対する懐疑的な見方は、潜在的な利用者を遠ざける可能性があります。嗜好が確立された製品にシフトするにつれて、メーカーは市場シェアを獲得する上で課題に直面する可能性があり、市場成長の妨げとなります。

COVID-19の影響：

COVID-19の大流行は、サプライチェーンを混乱させ、封鎖措置により対面販売を制限することで、ニコチン経口溶解性薄膜フィルム市場に影響を与えました。しかし、パンデミック時のストレスや禁煙への取り組みが、便利なニコチンデリバリー方法への需要に拍車をかけた。消費者が従来の喫煙に代わるものを求めるにつれ、これらのフィルムの認知度と採用率が高まり、メーカーはオンライン販売と流通戦略の強化を促しました。

ニコチンガム分野は予測期間中最大になると予想される

ニコチンガム分野は予測期間中最大になると予想されるが、これは両製品ともニコチンを効率的に供給し、欲求を管理することを目的としているためであり、市場内の競争を助長しています。ユーザーが薄膜とガムの利便性と吸収率を比較するにつれて、メーカー各社は自社の製品を強化するために技術革新を行う可能性があります。さらに、ニコチンガムの人気は、経口溶解性製品の認知度向上につながり、需要を促進し、消費者がさまざまな禁煙方法を模索することを促す可能性があります。

薬局セグメントは予測期間中最も高いCAGRが見込まれる

薬局は、消費者が禁煙補助剤に簡単にアクセスでき、その使用について専門家のアドバイスが受けられることから、予測期間中、薬局セグメントは最も高いCAGRを示すと予想されます。薬局では、従来のニコチンデリバリー方法の効果的な代替品としてこれらのフィルムを宣伝することが多く、認知度と採用率が高まる。さらに、薬剤師は個人に合わせた禁煙戦略を支援し、禁煙を支援する環境を醸成することができます。その結果、薬局の存在は市場の成長と消費者の関与にプラスの影響を与えます。

最大のシェアを占める地域：

北米は、禁煙補助製品に対する意識の高まりと、従来のタバコに代わる便利な代替品への需要により、予測期間中最大の市場シェアを占めると予測されます。これらのフィルムは迅速なニコチン吸収と目立たない使用を提供し、効果的な禁煙方法を求める消費者にアピールしています。さらに、規制当局の支援と製品処方の革新が市場拡大の原動力となっています。

CAGRが最も高い地域：

アジア太平洋地域は、予測期間中に最も高いCAGRを記録すると予測されます。これは、これらのフィルムが目立たず効果的なニコチンデリバリーを提供し、特に従来の喫煙方法に代わる方法を求める若い消費者にアピールするためです。タバコの使用に伴う健康リスクに対する意識の高まりと、それを後押しする規制が、市場の成長をさらに後押ししています。しかし、規制上のハードルや代替ニコチン供給システムとの競合といった課題は、市場力学に影響を与える可能性があります。

無料のカスタマイズサービス

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場プレイヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査情報源
  • 1次調査情報源
  • 2次調査情報源
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• 用途分析
• エンドユーザー分析
• 新興市場
• COVID-19の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界のニコチン経口溶解性薄膜市場：タイプ別

• ニコチン溶解フィルム
• ニコチンガム
• ニコチントローチ
• その他のタイプ

第6章 ニコチン経口溶解性薄膜の世界市場：投与強度別

• 低用量（1～2 mg）
• 高用量（4～6 mg）

第7章 世界のニコチン経口溶解性薄膜市場：流通チャネル別

• 薬局
• オンライン小売業者
• コンビニエンスストア
• スーパーマーケット/ハイパーマーケット

第8章 ニコチン経口溶解性薄膜の世界市場：用途別

• 禁煙
• ニコチン置換療法（NRT）
• レクリエーション利用
• その他の用途

第9章 世界のニコチン経口溶解性薄膜市場：エンドユーザー別

• 大人
• ティーンエイジャー

第10章 世界のニコチン経口溶解性薄膜市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第11章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品発売
• 事業拡大
• その他の主要戦略

第12章 企業プロファイリング

• 3M Drug Delivery Systems
• Aavishkar Oral Films
• Bespak Europe Ltd.
• Cure Pharmaceutical
• GlaxoSmithKline plc
• InnovaDerma
• IntelGenx Corp.
• Johnson & Johnson Services, Inc.
• MonoSol Rx
• Nicotine Polacrilex Films LLC
• Novartis AG
• Ocular Therapeutix, Inc.
• Oramed Pharmaceuticals Inc.
• OroVape
• Pfizer Inc.
• PharmaFilm
• Revolymer plc
• Striptek, Inc.
• Tesa Labtec GmbH
• Vivera Pharmaceuticals, Inc.

List of Tables

• Table 1 Global Nicotine Oral Dissolvable Thin Films Market Outlook, By Region (2022-2030) ($MN)
• Table 2 Global Nicotine Oral Dissolvable Thin Films Market Outlook, By Type (2022-2030) ($MN)
• Table 3 Global Nicotine Oral Dissolvable Thin Films Market Outlook, By Nicotine Dissolvable Films (2022-2030) ($MN)
• Table 4 Global Nicotine Oral Dissolvable Thin Films Market Outlook, By Nicotine Gums (2022-2030) ($MN)
• Table 5 Global Nicotine Oral Dissolvable Thin Films Market Outlook, By Nicotine Lozenges (2022-2030) ($MN)
• Table 6 Global Nicotine Oral Dissolvable Thin Films Market Outlook, By Other Types (2022-2030) ($MN)
• Table 7 Global Nicotine Oral Dissolvable Thin Films Market Outlook, By Dosage Strength (2022-2030) ($MN)
• Table 8 Global Nicotine Oral Dissolvable Thin Films Market Outlook, By Low Dose (1-2 mg) (2022-2030) ($MN)
• Table 9 Global Nicotine Oral Dissolvable Thin Films Market Outlook, By High Dose (4-6 mg) (2022-2030) ($MN)
• Table 10 Global Nicotine Oral Dissolvable Thin Films Market Outlook, By Distribution Channel (2022-2030) ($MN)
• Table 11 Global Nicotine Oral Dissolvable Thin Films Market Outlook, By Pharmacies (2022-2030) ($MN)
• Table 12 Global Nicotine Oral Dissolvable Thin Films Market Outlook, By Online Retailers (2022-2030) ($MN)
• Table 13 Global Nicotine Oral Dissolvable Thin Films Market Outlook, By Convenience Stores (2022-2030) ($MN)
• Table 14 Global Nicotine Oral Dissolvable Thin Films Market Outlook, By Supermarkets/Hypermarkets (2022-2030) ($MN)
• Table 15 Global Nicotine Oral Dissolvable Thin Films Market Outlook, By Application (2022-2030) ($MN)
• Table 16 Global Nicotine Oral Dissolvable Thin Films Market Outlook, By Smoking Cessation (2022-2030) ($MN)
• Table 17 Global Nicotine Oral Dissolvable Thin Films Market Outlook, By Nicotine Replacement Therapy (NRT) (2022-2030) ($MN)
• Table 18 Global Nicotine Oral Dissolvable Thin Films Market Outlook, By Recreational Use (2022-2030) ($MN)
• Table 19 Global Nicotine Oral Dissolvable Thin Films Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 20 Global Nicotine Oral Dissolvable Thin Films Market Outlook, By End User (2022-2030) ($MN)
• Table 21 Global Nicotine Oral Dissolvable Thin Films Market Outlook, By Adults (2022-2030) ($MN)
• Table 22 Global Nicotine Oral Dissolvable Thin Films Market Outlook, By Teenagers (2022-2030) ($MN)
• Table 23 North America Nicotine Oral Dissolvable Thin Films Market Outlook, By Country (2022-2030) ($MN)
• Table 24 North America Nicotine Oral Dissolvable Thin Films Market Outlook, By Type (2022-2030) ($MN)
• Table 25 North America Nicotine Oral Dissolvable Thin Films Market Outlook, By Nicotine Dissolvable Films (2022-2030) ($MN)
• Table 26 North America Nicotine Oral Dissolvable Thin Films Market Outlook, By Nicotine Gums (2022-2030) ($MN)
• Table 27 North America Nicotine Oral Dissolvable Thin Films Market Outlook, By Nicotine Lozenges (2022-2030) ($MN)
• Table 28 North America Nicotine Oral Dissolvable Thin Films Market Outlook, By Other Types (2022-2030) ($MN)
• Table 29 North America Nicotine Oral Dissolvable Thin Films Market Outlook, By Dosage Strength (2022-2030) ($MN)
• Table 30 North America Nicotine Oral Dissolvable Thin Films Market Outlook, By Low Dose (1-2 mg) (2022-2030) ($MN)
• Table 31 North America Nicotine Oral Dissolvable Thin Films Market Outlook, By High Dose (4-6 mg) (2022-2030) ($MN)
• Table 32 North America Nicotine Oral Dissolvable Thin Films Market Outlook, By Distribution Channel (2022-2030) ($MN)
• Table 33 North America Nicotine Oral Dissolvable Thin Films Market Outlook, By Pharmacies (2022-2030) ($MN)
• Table 34 North America Nicotine Oral Dissolvable Thin Films Market Outlook, By Online Retailers (2022-2030) ($MN)
• Table 35 North America Nicotine Oral Dissolvable Thin Films Market Outlook, By Convenience Stores (2022-2030) ($MN)
• Table 36 North America Nicotine Oral Dissolvable Thin Films Market Outlook, By Supermarkets/Hypermarkets (2022-2030) ($MN)
• Table 37 North America Nicotine Oral Dissolvable Thin Films Market Outlook, By Application (2022-2030) ($MN)
• Table 38 North America Nicotine Oral Dissolvable Thin Films Market Outlook, By Smoking Cessation (2022-2030) ($MN)
• Table 39 North America Nicotine Oral Dissolvable Thin Films Market Outlook, By Nicotine Replacement Therapy (NRT) (2022-2030) ($MN)
• Table 40 North America Nicotine Oral Dissolvable Thin Films Market Outlook, By Recreational Use (2022-2030) ($MN)
• Table 41 North America Nicotine Oral Dissolvable Thin Films Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 42 North America Nicotine Oral Dissolvable Thin Films Market Outlook, By End User (2022-2030) ($MN)
• Table 43 North America Nicotine Oral Dissolvable Thin Films Market Outlook, By Adults (2022-2030) ($MN)
• Table 44 North America Nicotine Oral Dissolvable Thin Films Market Outlook, By Teenagers (2022-2030) ($MN)
• Table 45 Europe Nicotine Oral Dissolvable Thin Films Market Outlook, By Country (2022-2030) ($MN)
• Table 46 Europe Nicotine Oral Dissolvable Thin Films Market Outlook, By Type (2022-2030) ($MN)
• Table 47 Europe Nicotine Oral Dissolvable Thin Films Market Outlook, By Nicotine Dissolvable Films (2022-2030) ($MN)
• Table 48 Europe Nicotine Oral Dissolvable Thin Films Market Outlook, By Nicotine Gums (2022-2030) ($MN)
• Table 49 Europe Nicotine Oral Dissolvable Thin Films Market Outlook, By Nicotine Lozenges (2022-2030) ($MN)
• Table 50 Europe Nicotine Oral Dissolvable Thin Films Market Outlook, By Other Types (2022-2030) ($MN)
• Table 51 Europe Nicotine Oral Dissolvable Thin Films Market Outlook, By Dosage Strength (2022-2030) ($MN)
• Table 52 Europe Nicotine Oral Dissolvable Thin Films Market Outlook, By Low Dose (1-2 mg) (2022-2030) ($MN)
• Table 53 Europe Nicotine Oral Dissolvable Thin Films Market Outlook, By High Dose (4-6 mg) (2022-2030) ($MN)
• Table 54 Europe Nicotine Oral Dissolvable Thin Films Market Outlook, By Distribution Channel (2022-2030) ($MN)
• Table 55 Europe Nicotine Oral Dissolvable Thin Films Market Outlook, By Pharmacies (2022-2030) ($MN)
• Table 56 Europe Nicotine Oral Dissolvable Thin Films Market Outlook, By Online Retailers (2022-2030) ($MN)
• Table 57 Europe Nicotine Oral Dissolvable Thin Films Market Outlook, By Convenience Stores (2022-2030) ($MN)
• Table 58 Europe Nicotine Oral Dissolvable Thin Films Market Outlook, By Supermarkets/Hypermarkets (2022-2030) ($MN)
• Table 59 Europe Nicotine Oral Dissolvable Thin Films Market Outlook, By Application (2022-2030) ($MN)
• Table 60 Europe Nicotine Oral Dissolvable Thin Films Market Outlook, By Smoking Cessation (2022-2030) ($MN)
• Table 61 Europe Nicotine Oral Dissolvable Thin Films Market Outlook, By Nicotine Replacement Therapy (NRT) (2022-2030) ($MN)
• Table 62 Europe Nicotine Oral Dissolvable Thin Films Market Outlook, By Recreational Use (2022-2030) ($MN)
• Table 63 Europe Nicotine Oral Dissolvable Thin Films Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 64 Europe Nicotine Oral Dissolvable Thin Films Market Outlook, By End User (2022-2030) ($MN)
• Table 65 Europe Nicotine Oral Dissolvable Thin Films Market Outlook, By Adults (2022-2030) ($MN)
• Table 66 Europe Nicotine Oral Dissolvable Thin Films Market Outlook, By Teenagers (2022-2030) ($MN)
• Table 67 Asia Pacific Nicotine Oral Dissolvable Thin Films Market Outlook, By Country (2022-2030) ($MN)
• Table 68 Asia Pacific Nicotine Oral Dissolvable Thin Films Market Outlook, By Type (2022-2030) ($MN)
• Table 69 Asia Pacific Nicotine Oral Dissolvable Thin Films Market Outlook, By Nicotine Dissolvable Films (2022-2030) ($MN)
• Table 70 Asia Pacific Nicotine Oral Dissolvable Thin Films Market Outlook, By Nicotine Gums (2022-2030) ($MN)
• Table 71 Asia Pacific Nicotine Oral Dissolvable Thin Films Market Outlook, By Nicotine Lozenges (2022-2030) ($MN)
• Table 72 Asia Pacific Nicotine Oral Dissolvable Thin Films Market Outlook, By Other Types (2022-2030) ($MN)
• Table 73 Asia Pacific Nicotine Oral Dissolvable Thin Films Market Outlook, By Dosage Strength (2022-2030) ($MN)
• Table 74 Asia Pacific Nicotine Oral Dissolvable Thin Films Market Outlook, By Low Dose (1-2 mg) (2022-2030) ($MN)
• Table 75 Asia Pacific Nicotine Oral Dissolvable Thin Films Market Outlook, By High Dose (4-6 mg) (2022-2030) ($MN)
• Table 76 Asia Pacific Nicotine Oral Dissolvable Thin Films Market Outlook, By Distribution Channel (2022-2030) ($MN)
• Table 77 Asia Pacific Nicotine Oral Dissolvable Thin Films Market Outlook, By Pharmacies (2022-2030) ($MN)
• Table 78 Asia Pacific Nicotine Oral Dissolvable Thin Films Market Outlook, By Online Retailers (2022-2030) ($MN)
• Table 79 Asia Pacific Nicotine Oral Dissolvable Thin Films Market Outlook, By Convenience Stores (2022-2030) ($MN)
• Table 80 Asia Pacific Nicotine Oral Dissolvable Thin Films Market Outlook, By Supermarkets/Hypermarkets (2022-2030) ($MN)
• Table 81 Asia Pacific Nicotine Oral Dissolvable Thin Films Market Outlook, By Application (2022-2030) ($MN)
• Table 82 Asia Pacific Nicotine Oral Dissolvable Thin Films Market Outlook, By Smoking Cessation (2022-2030) ($MN)
• Table 83 Asia Pacific Nicotine Oral Dissolvable Thin Films Market Outlook, By Nicotine Replacement Therapy (NRT) (2022-2030) ($MN)
• Table 84 Asia Pacific Nicotine Oral Dissolvable Thin Films Market Outlook, By Recreational Use (2022-2030) ($MN)
• Table 85 Asia Pacific Nicotine Oral Dissolvable Thin Films Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 86 Asia Pacific Nicotine Oral Dissolvable Thin Films Market Outlook, By End User (2022-2030) ($MN)
• Table 87 Asia Pacific Nicotine Oral Dissolvable Thin Films Market Outlook, By Adults (2022-2030) ($MN)
• Table 88 Asia Pacific Nicotine Oral Dissolvable Thin Films Market Outlook, By Teenagers (2022-2030) ($MN)
• Table 89 South America Nicotine Oral Dissolvable Thin Films Market Outlook, By Country (2022-2030) ($MN)
• Table 90 South America Nicotine Oral Dissolvable Thin Films Market Outlook, By Type (2022-2030) ($MN)
• Table 91 South America Nicotine Oral Dissolvable Thin Films Market Outlook, By Nicotine Dissolvable Films (2022-2030) ($MN)
• Table 92 South America Nicotine Oral Dissolvable Thin Films Market Outlook, By Nicotine Gums (2022-2030) ($MN)
• Table 93 South America Nicotine Oral Dissolvable Thin Films Market Outlook, By Nicotine Lozenges (2022-2030) ($MN)
• Table 94 South America Nicotine Oral Dissolvable Thin Films Market Outlook, By Other Types (2022-2030) ($MN)
• Table 95 South America Nicotine Oral Dissolvable Thin Films Market Outlook, By Dosage Strength (2022-2030) ($MN)
• Table 96 South America Nicotine Oral Dissolvable Thin Films Market Outlook, By Low Dose (1-2 mg) (2022-2030) ($MN)
• Table 97 South America Nicotine Oral Dissolvable Thin Films Market Outlook, By High Dose (4-6 mg) (2022-2030) ($MN)
• Table 98 South America Nicotine Oral Dissolvable Thin Films Market Outlook, By Distribution Channel (2022-2030) ($MN)
• Table 99 South America Nicotine Oral Dissolvable Thin Films Market Outlook, By Pharmacies (2022-2030) ($MN)
• Table 100 South America Nicotine Oral Dissolvable Thin Films Market Outlook, By Online Retailers (2022-2030) ($MN)
• Table 101 South America Nicotine Oral Dissolvable Thin Films Market Outlook, By Convenience Stores (2022-2030) ($MN)
• Table 102 South America Nicotine Oral Dissolvable Thin Films Market Outlook, By Supermarkets/Hypermarkets (2022-2030) ($MN)
• Table 103 South America Nicotine Oral Dissolvable Thin Films Market Outlook, By Application (2022-2030) ($MN)
• Table 104 South America Nicotine Oral Dissolvable Thin Films Market Outlook, By Smoking Cessation (2022-2030) ($MN)
• Table 105 South America Nicotine Oral Dissolvable Thin Films Market Outlook, By Nicotine Replacement Therapy (NRT) (2022-2030) ($MN)
• Table 106 South America Nicotine Oral Dissolvable Thin Films Market Outlook, By Recreational Use (2022-2030) ($MN)
• Table 107 South America Nicotine Oral Dissolvable Thin Films Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 108 South America Nicotine Oral Dissolvable Thin Films Market Outlook, By End User (2022-2030) ($MN)
• Table 109 South America Nicotine Oral Dissolvable Thin Films Market Outlook, By Adults (2022-2030) ($MN)
• Table 110 South America Nicotine Oral Dissolvable Thin Films Market Outlook, By Teenagers (2022-2030) ($MN)
• Table 111 Middle East & Africa Nicotine Oral Dissolvable Thin Films Market Outlook, By Country (2022-2030) ($MN)
• Table 112 Middle East & Africa Nicotine Oral Dissolvable Thin Films Market Outlook, By Type (2022-2030) ($MN)
• Table 113 Middle East & Africa Nicotine Oral Dissolvable Thin Films Market Outlook, By Nicotine Dissolvable Films (2022-2030) ($MN)
• Table 114 Middle East & Africa Nicotine Oral Dissolvable Thin Films Market Outlook, By Nicotine Gums (2022-2030) ($MN)
• Table 115 Middle East & Africa Nicotine Oral Dissolvable Thin Films Market Outlook, By Nicotine Lozenges (2022-2030) ($MN)
• Table 116 Middle East & Africa Nicotine Oral Dissolvable Thin Films Market Outlook, By Other Types (2022-2030) ($MN)
• Table 117 Middle East & Africa Nicotine Oral Dissolvable Thin Films Market Outlook, By Dosage Strength (2022-2030) ($MN)
• Table 118 Middle East & Africa Nicotine Oral Dissolvable Thin Films Market Outlook, By Low Dose (1-2 mg) (2022-2030) ($MN)
• Table 119 Middle East & Africa Nicotine Oral Dissolvable Thin Films Market Outlook, By High Dose (4-6 mg) (2022-2030) ($MN)
• Table 120 Middle East & Africa Nicotine Oral Dissolvable Thin Films Market Outlook, By Distribution Channel (2022-2030) ($MN)
• Table 121 Middle East & Africa Nicotine Oral Dissolvable Thin Films Market Outlook, By Pharmacies (2022-2030) ($MN)
• Table 122 Middle East & Africa Nicotine Oral Dissolvable Thin Films Market Outlook, By Online Retailers (2022-2030) ($MN)
• Table 123 Middle East & Africa Nicotine Oral Dissolvable Thin Films Market Outlook, By Convenience Stores (2022-2030) ($MN)
• Table 124 Middle East & Africa Nicotine Oral Dissolvable Thin Films Market Outlook, By Supermarkets/Hypermarkets (2022-2030) ($MN)
• Table 125 Middle East & Africa Nicotine Oral Dissolvable Thin Films Market Outlook, By Application (2022-2030) ($MN)
• Table 126 Middle East & Africa Nicotine Oral Dissolvable Thin Films Market Outlook, By Smoking Cessation (2022-2030) ($MN)
• Table 127 Middle East & Africa Nicotine Oral Dissolvable Thin Films Market Outlook, By Nicotine Replacement Therapy (NRT) (2022-2030) ($MN)
• Table 128 Middle East & Africa Nicotine Oral Dissolvable Thin Films Market Outlook, By Recreational Use (2022-2030) ($MN)
• Table 129 Middle East & Africa Nicotine Oral Dissolvable Thin Films Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 130 Middle East & Africa Nicotine Oral Dissolvable Thin Films Market Outlook, By End User (2022-2030) ($MN)
• Table 131 Middle East & Africa Nicotine Oral Dissolvable Thin Films Market Outlook, By Adults (2022-2030) ($MN)
• Table 132 Middle East & Africa Nicotine Oral Dissolvable Thin Films Market Outlook, By Teenagers (2022-2030) ($MN)

According to Stratistics MRC, the Global Nicotine Oral Dissolvable Thin Films Market is accounted for $0.11 billion in 2024 and is expected to reach $0.15 billion by 2030 growing at a CAGR of 5.86% during the forecast period. Nicotine oral dissolvable thin films are innovative smoking cessation products designed to deliver nicotine effectively while allowing for rapid absorption through the mucous membranes in the mouth. These thin, flexible films dissolve quickly, providing a discreet and convenient option for users seeking to manage cravings and reduce tobacco dependence. They are typically sugar-free and flavored, appealing to consumers who prefer an alternative to traditional nicotine replacement therapies like gums and patches. As a modern approach to smoking cessation, these films aim to support individuals in their journey to quit smoking.

Market Dynamics:

Driver:

Growing Smoking Cessation Awareness

Growing smoking cessation awareness significantly impacts the market by driving consumer demand for effective quitting aids. As public health campaigns and educational initiatives highlight the risks of smoking, more individuals are seeking alternatives to traditional tobacco products. This increased awareness promotes the adoption of innovative solutions like dissolvable films, which offer a discreet and convenient way to manage cravings. Consequently, manufacturers are encouraged to expand product offerings and marketing efforts, thus it boosts the growth of the market.

Restraint:

Limited Awareness

Limited awareness of nicotine oral dissolvable thin films hinders market growth, as potential users may not know about this effective smoking cessation alternative. This lack of familiarity can result in lower adoption rates, with consumers opting for more traditional nicotine products instead. Consequently, manufacturers face challenges in expanding their market presence and promoting the benefits of these innovative products. Thus, it hampers the growth of the market.

Opportunity:

Convenience and Discretion

Convenience and discretion are key factors influencing the market, as these products offer a portable and easy-to-use alternative for nicotine delivery. Their small size allows users to take them anywhere without drawing attention, appealing to those who seek a more private way to manage cravings. This convenience enhances user experience and encourages adoption, driving demand for these products. As consumers prioritize discreet options for quitting smoking, manufacturers are motivated to innovate and expand their offerings, further boosting market growth. Thus, it drives the growth of the market.

Threat:

Consumer Preferences

Consumer preferences can negatively impact the market if users favor other nicotine replacement products, such as gums, patches, or e-cigarettes. If consumers perceive these alternatives as more effective or easier to use, demand for thin films may decline. Additionally, skepticism about the efficacy or safety of dissolvable films can deter potential users. As preferences shift towards well-established products, manufacturers may face challenges in capturing market share, thus it hinders the growth of the market.

Covid-19 Impact:

The COVID-19 pandemic impacted the nicotine oral dissolvable thin films market by disrupting supply chains and limiting in-person sales due to lockdown measures. However, stress and smoking cessation efforts during the pandemic spurred demand for convenient nicotine delivery methods. As consumers sought alternatives to traditional smoking, awareness and adoption of these films grew, prompting manufacturers to enhance online sales and distribution strategies.

The nicotine gums segment is expected to be the largest during the forecast period

The nicotine gums segment is expected to be the largest during the forecast period because both products aim to deliver nicotine effectively and help manage cravings, which fosters competition within the market. As users compare the convenience and absorption rates of thin films against gums, manufacturers may innovate to enhance their offerings. Additionally, the popularity of nicotine gums can lead to greater awareness of oral dissolvable products, driving demand and encouraging consumers to explore various cessation methods.

The pharmacies segment is expected to have the highest CAGR during the forecast period

The pharmacies segment is expected to have the highest CAGR during the forecast period as they provide consumers with easy access to smoking cessation aids and expert advice on their use. Pharmacies often promote these films as effective alternatives to traditional nicotine delivery methods, enhancing awareness and adoption. Additionally, pharmacists can assist in tailoring cessation strategies for individuals, fostering a supportive environment for quitting smoking. As a result, the presence of pharmacies positively influences market growth and consumer engagement.

Region with largest share:

North America is projected to hold the largest market share during the forecast period owing to increasing awareness of smoking cessation products and the demand for convenient alternatives to traditional tobacco. These films offer rapid nicotine absorption and discreet use, appealing to consumers seeking effective ways to quit smoking. Additionally, regulatory support and innovations in product formulations are driving market expansion.

Region with highest CAGR:

Asia Pacific is projected to witness the highest CAGR over the forecast period as these films offer discreet and effective nicotine delivery, appealing particularly to younger consumers seeking alternatives to traditional smoking methods. Increased awareness of health risks associated with tobacco use and supportive regulations are further propelling market growth. However, challenges such as regulatory hurdles and competition from alternative nicotine delivery systems may impact market dynamics.

Key players in the market

Some of the key players in Nicotine Oral Dissolvable Thin Films Market include 3M Drug Delivery Systems, Aavishkar Oral Films, Bespak Europe Ltd., Cure Pharmaceutical, GlaxoSmithKline plc, InnovaDerma, IntelGenx Corp., Johnson & Johnson Services, Inc., MonoSol Rx, Nicotine Polacrilex Films LLC, Novartis AG, Ocular Therapeutix, Inc., Oramed Pharmaceuticals Inc., OroVape, Pfizer Inc., PharmaFilm, Revolymer plc, Striptek, Inc., Tesa Labtec GmbH and Vivera Pharmaceuticals, Inc.

Key Developments:

In October 2024, Johnson & Johnson MedTech, announced the first phase of the VOLT Variable Angle Optimized Locking Technology Plating System launch. The innovative system represents an evolution in our fracture management solutions designed to improve stability, enhance performance and increase efficiency.

In October 2024, Johnson & Johnson announced a collaborative effort with the U.S. Agency for International Development (USAID) and the Johnson & Johnson (J&J) Foundation to expand support for health workers across Latin America and the Caribbean.

In August 2024, Pfizer Launched PfizerForAll, a user-friendly digital platform designed to make access to healthcare and managing health and wellness more seamless for people across the U.S.

Types Covered:

• Nicotine Dissolvable Films
• Nicotine Gums
• Nicotine Lozenges
• Other Types

Dosage Strengths Covered:

• Low Dose (1-2 mg)
• High Dose (4-6 mg)

Distribution Channels Covered:

• Pharmacies
• Online Retailers
• Convenience Stores
• Supermarkets/Hypermarkets

Applications Covered:

• Smoking Cessation
• Nicotine Replacement Therapy (NRT)
• Recreational Use
• Other Applications

End Users Covered:

• Adults
• Teenagers

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Nicotine Oral Dissolvable Thin Films Market, By Type

• 5.1 Introduction
• 5.2 Nicotine Dissolvable Films
• 5.3 Nicotine Gums
• 5.4 Nicotine Lozenges
• 5.5 Other Types

6 Global Nicotine Oral Dissolvable Thin Films Market, By Dosage Strength

• 6.1 Introduction
• 6.2 Low Dose (1-2 mg)
• 6.3 High Dose (4-6 mg)

7 Global Nicotine Oral Dissolvable Thin Films Market, By Distribution Channel

• 7.1 Introduction
• 7.2 Pharmacies
• 7.3 Online Retailers
• 7.4 Convenience Stores
• 7.5 Supermarkets/Hypermarkets

8 Global Nicotine Oral Dissolvable Thin Films Market, By Application

• 8.1 Introduction
• 8.2 Smoking Cessation
• 8.3 Nicotine Replacement Therapy (NRT)
• 8.4 Recreational Use
• 8.5 Other Applications

9 Global Nicotine Oral Dissolvable Thin Films Market, By End User

• 9.1 Introduction
• 9.2 Adults
• 9.3 Teenagers

10 Global Nicotine Oral Dissolvable Thin Films Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 3M Drug Delivery Systems
• 12.2 Aavishkar Oral Films
• 12.3 Bespak Europe Ltd.
• 12.4 Cure Pharmaceutical
• 12.5 GlaxoSmithKline plc
• 12.6 InnovaDerma
• 12.7 IntelGenx Corp.
• 12.8 Johnson & Johnson Services, Inc.
• 12.9 MonoSol Rx
• 12.10 Nicotine Polacrilex Films LLC
• 12.11 Novartis AG
• 12.12 Ocular Therapeutix, Inc.
• 12.13 Oramed Pharmaceuticals Inc.
• 12.14 OroVape
• 12.15 Pfizer Inc.
• 12.16 PharmaFilm
• 12.17 Revolymer plc
• 12.18 Striptek, Inc.
• 12.19 Tesa Labtec GmbH
• 12.20 Vivera Pharmaceuticals, Inc.